These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16640031)

  • 21. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum.
    Guilarte M; Santos J; de Torres I; Alonso C; Vicario M; Ramos L; Martínez C; Casellas F; Saperas E; Malagelada JR
    Gut; 2007 Feb; 56(2):203-9. PubMed ID: 17005763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mast Cells in Irritable Bowel Syndrome: A Systematic Review.
    Krammer L; Sowa AS; Lorentz A
    J Gastrointestin Liver Dis; 2019 Dec; 28(4):463-472. PubMed ID: 31826052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative Analysis of Intramucosal Mast Cells in Irritable Bowel Syndrome: A Comparison With Inflammatory Bowel Disease in Remission.
    Fan L; Wong M; Fan XS; Hong Y; Sun K; Jiang C; Xie X; Wang HL
    J Clin Gastroenterol; 2021 Mar; 55(3):244-249. PubMed ID: 32649443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activated mast cells infiltrate in close proximity to enteric nerves in diarrhea-predominant irritable bowel syndrome.
    Park CH; Joo YE; Choi SK; Rew JS; Kim SJ; Lee MC
    J Korean Med Sci; 2003 Apr; 18(2):204-10. PubMed ID: 12692417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is irritable bowel syndrome an inflammatory disorder?
    De Giorgio R; Barbara G
    Curr Gastroenterol Rep; 2008 Aug; 10(4):385-90. PubMed ID: 18627650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nerve growth factor content is increased in the rectal mucosa of children with diarrhea-predominant irritable bowel syndrome.
    Willot S; Gauthier C; Patey N; Faure C
    Neurogastroenterol Motil; 2012 Aug; 24(8):734-9, e347. PubMed ID: 22625872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting.
    De Silva AP; Nandasiri SD; Hewavisenthi J; Manamperi A; Ariyasinghe MP; Dassanayake AS; Jewell DP; de Silva HJ
    Scand J Gastroenterol; 2012 Jun; 47(6):619-24. PubMed ID: 22486731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.
    Cremon C; Gargano L; Morselli-Labate AM; Santini D; Cogliandro RF; De Giorgio R; Stanghellini V; Corinaldesi R; Barbara G
    Am J Gastroenterol; 2009 Feb; 104(2):392-400. PubMed ID: 19174797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The functional-organic dichotomy: postinfectious irritable bowel syndrome and inflammatory bowel disease-irritable bowel syndrome.
    Grover M; Herfarth H; Drossman DA
    Clin Gastroenterol Hepatol; 2009 Jan; 7(1):48-53. PubMed ID: 18848909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Increase of intraepithelial lymphocytes in patients with irritable bowel syndrome].
    Arévalo F; Aragon V; Montes P; Guzmán E; Monge E
    Rev Gastroenterol Peru; 2011; 31(4):315-8. PubMed ID: 22476118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome.
    Klooker TK; Braak B; Koopman KE; Welting O; Wouters MM; van der Heide S; Schemann M; Bischoff SC; van den Wijngaard RM; Boeckxstaens GE
    Gut; 2010 Sep; 59(9):1213-21. PubMed ID: 20650926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations.
    Martínez C; Vicario M; Ramos L; Lobo B; Mosquera JL; Alonso C; Sánchez A; Guilarte M; Antolín M; de Torres I; González-Castro AM; Pigrau M; Saperas E; Azpiroz F; Santos J
    Am J Gastroenterol; 2012 May; 107(5):736-46. PubMed ID: 22415197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome.
    Dothel G; Barbaro MR; Boudin H; Vasina V; Cremon C; Gargano L; Bellacosa L; De Giorgio R; Le Berre-Scoul C; Aubert P; Neunlist M; De Ponti F; Stanghellini V; Barbara G
    Gastroenterology; 2015 May; 148(5):1002-1011.e4. PubMed ID: 25655556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS.
    Di Nardo G; Barbara G; Cucchiara S; Cremon C; Shulman RJ; Isoldi S; Zecchi L; Drago L; Oliva S; Saulle R; Barbaro MR; Stronati L
    Neurogastroenterol Motil; 2014 Feb; 26(2):196-204. PubMed ID: 24304324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease.
    Bischoff SC; Wedemeyer J; Herrmann A; Meier PN; Trautwein C; Cetin Y; Maschek H; Stolte M; Gebel M; Manns MP
    Histopathology; 1996 Jan; 28(1):1-13. PubMed ID: 8838115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Terminal ileal mucosal mast cells in irritable bowel syndrome.
    Weston AP; Biddle WL; Bhatia PS; Miner PB
    Dig Dis Sci; 1993 Sep; 38(9):1590-5. PubMed ID: 8359068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome?
    Burgmann T; Clara I; Graff L; Walker J; Lix L; Rawsthorne P; McPhail C; Rogala L; Miller N; Bernstein CN
    Clin Gastroenterol Hepatol; 2006 May; 4(5):614-20. PubMed ID: 16630762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patients' perception of colonoscopy: patients with inflammatory bowel disease and irritable bowel syndrome experience the largest burden.
    Denters MJ; Schreuder M; Depla AC; Mallant-Hent RC; van Kouwen MC; Deutekom M; Bossuyt PM; Fockens P; Dekker E
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):964-72. PubMed ID: 23660935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mast cells and nerves tickle in the tummy: implications for inflammatory bowel disease and irritable bowel syndrome.
    Rijnierse A; Nijkamp FP; Kraneveld AD
    Pharmacol Ther; 2007 Nov; 116(2):207-35. PubMed ID: 17719089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of mast cells and eosinophils in neuroimmune interactions regulating mucosal inflammation in inflammatory bowel disease.
    Bischoff SC; Gebhardt T
    Adv Exp Med Biol; 2006; 579():177-208. PubMed ID: 16620019
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.